We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

141 hedge funds and large institutions have $1.69B invested in Adverum Biotechnologies in 2020 Q2 according to their latest regulatory filings, with 29 funds opening new positions, 60 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

211% more call options, than puts

Call options by funds: $15.9M | Put options by funds: $5.1M

114% more capital invested

Capital invested by funds: $790M → $1.69B (+$899M)

107% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 14

58% more repeat investments, than reductions

Existing positions increased: 60 | Existing positions reduced: 38

14% more funds holding in top 10

Funds holding in top 10: 7 → 8 (+1)

12% more funds holding

Funds holding: 126 → 141 (+15)

0.07% less ownership

Funds ownership: 10.14% → 10.07% (-0.07%)

Holders
141
Holders Change
+15
Holders Change %
+11.9%
% of All Funds
2.89%
Holding in Top 10
8
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+14.29%
% of All Funds
0.16%
New
29
Increased
60
Reduced
38
Closed
14
Calls
$15.9M
Puts
$5.1M
Net Calls
+$10.8M
Net Calls Change
-$273K

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$22M
2
BlackRock
BlackRock
New York
+$15.3M
3
CC
Casdin Capital
New York
+$13.1M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$11.8M
5
RCM
RA Capital Management
Massachusetts
+$9.37M

Top Sellers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
-$25.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$23M
3
DM
Deerfield Management
New York
-$22M
4
UBS Group
UBS Group
Switzerland
-$14.4M
5
VA
VR Adviser
New York
-$9.71M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
76
American International Group
New York
$933K +$128K +723 +19%
Deutsche Bank
77
Deutsche Bank
Germany
$903K -$1.09M -6,157 -59%
Manulife (Manufacturers Life Insurance)
78
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$901K +$77.8K +439 +11%
Russell Investments Group
79
Russell Investments Group
United Kingdom
$883K +$224K +1,262 +42%
AC
80
Athanor Capital
New York
$831K +$705K +3,981 New
MSL
81
Mackay Shields LLC
New York
$794K +$673K +3,800 New
Rafferty Asset Management
82
Rafferty Asset Management
New York
$723K +$389K +2,199 +174%
MIM
83
MetLife Investment Management
New Jersey
$681K +$71.7K +405 +14%
State Board of Administration of Florida Retirement System
84
State Board of Administration of Florida Retirement System
Florida
$653K +$136K +770 +33%
AG
85
Algert Global
California
$625K – – –
QSS
86
Quantitative Systematic Strategies
Florida
$619K +$27.3K +154 +5%
SFI
87
Susquehanna Fundamental Investments
Pennsylvania
$583K +$494K +2,790 New
Principal Financial Group
88
Principal Financial Group
Iowa
$571K +$306K +1,728 +171%
VF
89
Virtu Financial
New York
$562K +$477K +2,692 New
HS
90
HighVista Strategies
Massachusetts
$547K +$464K +2,620 New
VOYA Investment Management
91
VOYA Investment Management
Georgia
$529K -$108K -607 -19%
FAM
92
Fred Alger Management
New York
$522K +$443K +2,500 New
IC
93
Ikarian Capital
Texas
$477K +$405K +2,284 New
ProShare Advisors
94
ProShare Advisors
Maryland
$475K +$182K +1,026 +82%
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$470K +$46.6K +263 +13%
Legal & General Group
96
Legal & General Group
United Kingdom
$407K +$127K +718 +58%
NIT
97
NumerixS Investment Technologies
British Columbia, Canada
$393K +$333K +1,883 New
SEI Investments
98
SEI Investments
Pennsylvania
$388K +$329K +1,859 New
VEA
99
Virtus ETF Advisers
New York
$343K -$313K -1,768 -52%
JMPWA
100
JP Morgan Private Wealth Advisors
California
$327K -$76.7K -433 -22%
2 3
4
5 6

ADVM Hedge Fund Activity: Q2 2020 in Review

141 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q2 2020, worth a combined $1.69B — up 114% from $790M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new ADVM positions and 14 closed out — a net gain of 15 holders — while 60 added to existing stakes and 38 trimmed.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $22M. The largest seller was Victory Capital Management, cutting an estimated $25.8M.

  • 141 institutional investors held Adverum Biotechnologies (ADVM) as of Q2 2020, up from 126 in Q1 2020.
  • Funds reported $1.69B of Adverum Biotechnologies stock for Q2 2020, up 114% quarter-over-quarter.
  • 29 funds opened new Adverum Biotechnologies positions in Q2 2020 and 14 closed out, a net change of +15 holders.
  • The largest Adverum Biotechnologies buyer in Q2 2020 was Wellington Management Group, an estimated $22M added.
  • The largest Adverum Biotechnologies seller in Q2 2020 was Victory Capital Management, an estimated $25.8M sold.

Based on aggregated 13F filings for Q2 2020.